Biochemistry and molecular cell biology of diabetic complications (original) (raw)
The Diabetes Control and Complications Trial Research Group. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N. Engl. J. Med.329, 977–986 (1993).
UK Prospective Diabetes Study (UKPDS) Group. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). Lancet352, 837–853 (1998).
Wei, M., Gaskill, S. P., Haffner, S. M. & Stern, M. P. Effects of diabetes and level of glycemia on all-cause and cardiovascular mortality. The San Antonio Heart Study. Diabetes Care7, 1167–1172 (1998). Article Google Scholar
Ebara, T. et al. Delayed catabolism of apoB-48 lipoproteins due to decreased heparan sulfate proteoglycan production in diabetic mice. J. Clin. Invest.105, 1807–1818 (2000). ArticleCASPubMedPubMed Central Google Scholar
Hsueh, W. A. & Law, R. E. Cardiovascular risk continuum: implications of insulin resistance and diabetes. Am. J. Med.105, 4S–14S (1998). ArticleCASPubMed Google Scholar
Jiang, Z. Y. et al. Characterization of selective resistance to insulin signaling in the vasculature of obese Zucker (fa/fa) rats. J. Clin. Invest.104, 447–457 (1999). ArticleCASPubMedPubMed Central Google Scholar
Williams, S. B. et al. Acute hyperglycemia attenuates endothelium-dependent vasodilation in humans in vivo. Circulation97, 1695–1701 (1998). ArticleCASPubMed Google Scholar
Du, X. L. et al. Hyperglycemia-induced mitochondrial superoxide overproduction activates the hexosamine pathway and induces plasminogen activator inhibitor-1 expression by increasing Sp1 glycosylation. Proc. Natl Acad. Sci. USA97, 12222–12226 (2000). ArticleADSCASPubMedPubMed Central Google Scholar
Temelkova-Kurktschiev, T. S. et al. Postchallenge plasma glucose and glycemic spikes are more strongly associated with atherosclerosis than fasting glucose or HbA1c levels. Diabetes Care12, 1830–1834 (2000). Article Google Scholar
Wilson, D. K., Bohren, K. M., Gabbay, K. H. & Quiocho, F. A. An unlikely sugar substrate site in the 1.65 A structure of the human aldose reductase holoenzyme implicated in diabetic complications. Science257, 81–84 (1992). ArticleADSCASPubMed Google Scholar
Xia, P., Kramer, R. M. & King, G. L. Identification of the mechanism for the inhibition of Na,K-adenosine triphosphatase bv hyperglycemia involving activation of protein kinase C and cytosolic phospholipase A2. J. Clin. Invest.96, 733–740 (1995). ArticleCASPubMedPubMed Central Google Scholar
Williamson, J. R. et al. Hyperglycemic pseudohypoxia and diabetic complications. Diabetes42, 801–813 (1993). ArticleCASPubMed Google Scholar
Garcia Soriano, F. et al. Diabetic endothelial dysfunction: the role of poly(ADP-ribose) polymerase activation. Nature Med.7, 108–113 (2001). ArticleCASPubMed Google Scholar
Lee, A. Y. & Chung, S. S. Contributions of polyol pathway to oxidative stress in diabetic cataract. FASEB J.13, 23–30 (1999). ArticleCASPubMed Google Scholar
Engerman, R. L., Kern, T. S. & Larson, M. E. Nerve conduction and aldose reductase inhibition during 5 years of diabetes or galactosaemia in dogs. Diabetologia37, 141–144 (1994). ArticleCASPubMed Google Scholar
Sorbinil Retinopathy Trial Research Group. A randomized trial of sorbinil, an aldose reductase inhibitor, in diabetic retinopathy. Arch. Ophthalmol.108, 1234–1244 (1990).
Greene, D. A., Arezzo, J. C. & Brown, M. B. Effect of aldose reductase inhibition on nerve conduction and morphometry in diabetic neuropathy. Zenarestat Study Group. Neurology53, 580–591 (1999). ArticleCASPubMed Google Scholar
Stitt, A. W. et al. Advanced glycation end products (AGEs) co-localize with AGE receptors in the retinal vasculature of diabetic and of AGE-infused rats. Am. J. Pathol.150, 523–528 (1997). CASPubMedPubMed Central Google Scholar
Horie, K. et al. Immunohistochemical colocalization of glycoxidation products and lipid peroxidation products in diabetic renal glomerular lesions. Implication for glycoxidative stress in the pathogenesis of diabetic nephropathy. J. Clin. Invest.100, 2995–2999 (1997). ArticleCASPubMedPubMed Central Google Scholar
Degenhardt, T. P., Thorpe, S. R. & Baynes, J. W. Chemical modification of proteins by methylglyoxal. Cell Mol. Biol.44, 1139–1145 (1998). CASPubMed Google Scholar
Wells-Knecht, K. J. et al. Mechanism of autoxidative glycosylation: identification of glyoxal and arabinose as intermediates in the autoxidative modification of proteins by glucose. Biochemistry34, 3702–3709 (1995). ArticleCASPubMed Google Scholar
Thornalley, P. J. The glyoxalase system: new developments towards functional characterization of a metabolic pathway fundamental to biological life. Biochem J.269, 1–11 (1990). ArticleCASPubMedPubMed Central Google Scholar
Suzuki, K. et al. Overexpression of aldehyde reductase protects PC12 cells from the cytotoxicity of methylglyoxal or 3-deoxyglucosone. J. Biochem.123, 353–357 (1998). ArticleCASPubMed Google Scholar
Soulis-Liparota T., Cooper, M., Papazoglou, D., Clarke, B. & Jerums, G. Retardation by aminoguanidine of development of albuminuria, mesangial expansion, and tissue fluorescence in streptozocin-induced diabetic rat. Diabetes40, 1328–1334 (1991). ArticleCASPubMed Google Scholar
Nakamura, S. et al. Progression of nephropathy in spontaneous diabetic rats is prevented by OPB-9195, a novel inhibitor of advanced glycation. Diabetes46, 895–899 (1997). ArticleCASPubMed Google Scholar
Hammes, H-P. et al. Aminoguanidine treatment inhibits the development of experimental diabetic retinopathy. Proc. Natl Acad. Sci. USA88, 11555–11559 (1991). ArticleADSCASPubMedPubMed Central Google Scholar
Giardino, I., Edelstein, D. & Brownlee, M. Nonenzymatic glycosylation in vitro and in bovine endothelial cells alters basic fibroblast growth factor activity. A model for intracellular glycosylation in diabetes. J. Clin. Invest.94, 110–117 (1994). ArticleCASPubMedPubMed Central Google Scholar
Shinohara, M. et al. Overexpression of glyoxalase-I in bovine endothelial cells inhibits intracellular advanced glycation endproduct formation and prevents hyperglycemia-induced increases in macromolecular endocytosis. J. Clin. Invest.101, 1142–1147 (1998). ArticleCASPubMedPubMed Central Google Scholar
Maisonpierre, P. C. et al. Angiopoietin-2, a natural antagonist for Tie2 that disrupts in vivo angiogenesis. Science277, 55–60 (1997). ArticleCASPubMed Google Scholar
Tanaka, S., Avigad, G., Brodsky, B. & Eikenberry, E. F. Glycation induces expansion of the molecular packing of collagen. J. Mol. Biol.203, 495–505 (1988). ArticleCASPubMed Google Scholar
Huijberts, M. S. P. et al. Aminoguanidine treatment increases elasticity and decreases fluid filtration of large arteries from diabetic rats. J. Clin. Invest.92, 1407–1411 (1993). ArticleCASPubMedPubMed Central Google Scholar
Tsilbary, E. C. et al. The effect of nonenzymatic glucosylation the binding of the main noncollagenous NC1 domain to type IV collagen. J. Biol. Chem.263, 4302–4308 (1990). Article Google Scholar
Charonis, A. S. et al. Laminin alterations after in vitro nonenzymatic glucosylation. Diabetes39, 807–814 (1988). Article Google Scholar
Haitoglou, C. S., Tsilibary, E. C., Brownlee, M. & Charonis, A. S. Altered cellular interactions between endothelial cells and nonenzymatically glucosylated laminin/type IV collagen. J. Biol. Chem.267, 12404–12407 (1992). ArticleCASPubMed Google Scholar
Federoff, H. J., Lawrence, D. & Brownlee, M. Nonenzymatic glycosylation of laminin and the laminin peptide CIKVAVS inhibits neurite outgrowth. Diabetes42, 509–513 (1993). ArticleCASPubMed Google Scholar
Li, Y. M. et al. Molecular identity and cellular distribution of advanced glycation endproduct receptors: relationship of p60 to OST-48 and p90 to 80K-H membrane proteins. Proc. Natl Acad. Sci. USA93, 11047–11052 (1996). ArticleADSCASPubMedPubMed Central Google Scholar
Smedsrod, B. et al. Advanced glycation end products are eliminated by scavenger-receptor-mediated endocytosis in hepatic sinusoidal kupffer and endothelial cells. Biochem J.322, 567–573 (1997). ArticleCASPubMedPubMed Central Google Scholar
Vlassara, H. et al. Identification of galectin-3 as a high-affinity binding protein for advanced glycation end products (AGE): a new member of the AGE-receptor complex. Mol. Med.1, 634–646 (1995). ArticleCASPubMedPubMed Central Google Scholar
Neeper, M. et al. Cloning and expression of RAGE: a cell surface receptor for advanced glycosylation end products of proteins. J. Biol. Chem.267, 14998–15004 (1992). ArticleCASPubMed Google Scholar
Vlassara, H. et al. Cachectin/TNF and IL-1 induced by glucose-modified proteins: role in normal tissue remodeling. Science240, 1546–1548 (1988). ArticleADSCASPubMed Google Scholar
Kirstein, M., Aston, C., Hintz, R. & Vlassara, H. Receptor-specific induction of insulin-like growth factor I in human monocytes by advanced glycosylation end product-modified proteins. J. Clin. Invest.90, 439–446 (1992). ArticleCASPubMedPubMed Central Google Scholar
Abordo, E. A., Westwood, M. E. & Thornalley, P. J. Synthesis and secretion of macrophage colony stimulating factor by mature human monocytes and human monocytic THP-1 cells induced by human serum albumin derivatives modified with methylglyoxal and glucose-derived advanced glycation endproducts. Immunol. Lett.53, 7–13 (1996). ArticleCASPubMed Google Scholar
Skolnik, E. Y. et al. Human and rat mesangial cell receptors for glucose-modified proteins: potential role in kidney tissue remodelling and diabetic nephropathy. J. Exp. Med.174, 931–939 (1991). ArticleCASPubMed Google Scholar
Doi, T. et al. Receptor specific increase in extracellular matrix productions in mouse mesangial cells by advanced glycosylation end products is mediated via platelet derived growth factor. Proc. Natl Acad. Sci. USA89, 2873–2877 (1992). ArticleADSCASPubMedPubMed Central Google Scholar
Schmidt, A. M. et al. Advanced glycation endproducts interacting with their endothelial receptor induce expression of vascular cell adhesion molecule-1 (VCAM-1) in cultured human endothelial cells and in mice: a potential mechanism for the accelerated vasculopathy of diabetes. J. Clin. Invest.96, 1395–1403 (1995). ArticleCASPubMedPubMed Central Google Scholar
Lu, M. et al. Advanced glycation end products increase retinal vascular endothelial growth factor expression. J. Clin. Invest.101, 1219–1224 (1998). ArticleCASPubMedPubMed Central Google Scholar
Park, L. et al. Suppression of accelerated diabetic atherosclerosis by the soluble receptor for advanced glycation endproducts. Nature Med.4, 1025–1031 (1998). ArticleCASPubMed Google Scholar
Yan, S. D. et al. Enhanced cellular oxidant stress by the interaction of advanced glycation end products with their receptors/binding proteins. J. Biol. Chem.269, 9889–9897 (1994). ArticleCASPubMed Google Scholar
Lander, H. M. et al. Activation of the receptor for advanced glycation end products triggers a p21(ras)-dependent mitogen-activated protein kinase pathway regulated by oxidant stress. J. Biol. Chem.272, 17810–17814 (1997). ArticleCASPubMed Google Scholar
Yamagishi, S. et al. Advanced glycation endproducts inhibit prostacyclin production and induce plasminogen activator inhibitor-1 in human microvascular endothelial cells. Diabetologia41, 1435–1441 (1998). ArticleCASPubMed Google Scholar
Tsuji, H. et al. Ribozyme targeting of receptor for advanced glycation end products in mouse mesangial cells. Biochem. Biophys. Res. Commun.245, 583–588 (1998). ArticleCASPubMed Google Scholar
Koya, D. & King, G. L. Protein kinase C activation and the development of diabetic complications. Diabetes47, 859–866 (1998). ArticleCASPubMed Google Scholar
Xia, P. et al. Characterization of the mechanism for the chronic activation of diacylglycerol-protein kinase C pathway in diabetes and hypergalactosemia. Diabetes43, 1122–1129 (1994). ArticleCASPubMed Google Scholar
Koya, D. et al. Characterization of protein kinase C beta isoform activation on the gene expression of transforming growth factor-beta, extracellular matrix components, and prostanoids in the glomeruli of diabetic rats. J. Clin. Invest.100, 115–126 (1997). ArticleCASPubMedPubMed Central Google Scholar
Portilla, D. et al. Etomoxir -induced PPARalpha-modulated enzymes protect during acute renal failure. Am. J. Physiol. Renal Physiol.278, F667–F675 (2000). ArticleCASPubMed Google Scholar
Keogh, R. J., Dunlop, M. E. & Larkins R. G. . Effect of inhibition of aldose reductase on glucose flux, diacylglycerol formation, protein kinase C, and phospholipase A2 activation. Metabolism46, 41–47 (1997). ArticleCASPubMed Google Scholar
Ishii, H. et al. Amelioration of vascular dysfunctions in diabetic rats by an oral PKC beta inhibitor. Science272, 728–731 (1996). ArticleADSCASPubMed Google Scholar
Craven, P. A., Studer, R. K. & DeRubertis, F. R. Impaired nitric oxide-dependent cyclic guanosine monophosphate generation in glomeruli from diabetic rats. Evidence for protein kinase C-mediated suppression of the cholinergic response. J. Clin. Invest.93, 311–320 (1994). ArticleCASPubMedPubMed Central Google Scholar
Ganz, M. B. & Seftel, A. Glucose-induced changes in protein kinase C and nitric oxide are prevented by vitamin E. Am. J. Physiol.278, E146–E152 (2000). CAS Google Scholar
Kuboki, K. et al. Regulation of endothelial constitutive nitric oxide synthase gene expression in endothelial cells and in vivo a specific vascular action of insulin. Circulation101, 676–681 (2000). ArticleCASPubMed Google Scholar
Glogowski, E. A., Tsiani, E., Zhou, X., Fantus, I. G. & Whiteside, C. High glucose alters the response of mesangial cell protein kinase C isoforms to endothelin-1. Kidney Int.55, 486–499 (1999). ArticleCASPubMed Google Scholar
Hempel, A. et al. High glucose concentrations increase endothelial cell permeability via activation of protein kinase C alpha. Circ. Res.81, 363–371 (1997). ArticleCASPubMed Google Scholar
Williams, B., Gallacher, B., Patel, H. & Orme, C. Glucose-induced protein kinase C activation regulates vascular permeability factor mRNA expression and peptide production by human vascular smooth muscle cells in vitro. Diabetes46, 1497–1503 (1997). ArticleCASPubMed Google Scholar
Studer, R. K., Craven, P. A. & DeRubertis, F. R. Role for protein kinase C in the mediation of increased fibronectin accumulation by mesangial cells grown in high-glucose medium. Diabetes42, 118–126 (1993). ArticleCASPubMed Google Scholar
Koya, D. et al. Characterization of protein kinase C beta isoform activation on the gene expression of transforming growth factor-beta, extracellular matrix components, and prostanoids in the glomeruli of diabetic rats. J. Clin. Invest.100, 115–126 (1997). ArticleCASPubMedPubMed Central Google Scholar
Craven, P. A., Studer, R. K., Felder, J., Phillips, S. & DeRubertis, F. R. Nitric oxide inhibition of transforming growth factor-beta and collagen synthesis in mesangial cells. Diabetes46, 671–681 (1997). ArticleCASPubMed Google Scholar
Phillips, S. L., DeRubertis, F. R. & Craven, P. A. Regulation of the laminin C1 promoter in cultured mesangial cells. Diabetes48, 2083–2089 (1999). ArticleCASPubMed Google Scholar
Feener, E. P. et al. Role of protein kinase C in glucose- and angiotensin II-induced plasminogen activator inhibitor expression. Contrib. Nephrol.118, 180–187 (1996). ArticleCASPubMed Google Scholar
Pieper, G. M. & Riaz-ul-Haq, J. Activation of nuclear factor-kappaB in cultured endothelial cells by increased glucose concentration: prevention by calphostin C. Cardiovasc. Pharmacol.30, 528–532 (1997). ArticleCAS Google Scholar
Yerneni, K. K., Bai, W., Khan, B. V., Medford, R. M. & Natarajan, R. Hyperglycemia-induced activation of nuclear transcription factor kappaB in vascular smooth muscle cells. Diabetes48, 855–864 (1999). ArticleCASPubMed Google Scholar
Koya, D. et al. Amelioration of accelerated diabetic mesangial expansion by treatment with a PKC beta inhibitor in diabetic db/db mice, a rodent model for type 2 diabetes. FASEB J.14, 439–447 (2000). ArticleCASPubMed Google Scholar
Kolm-Litty, V., Sauer, U., Nerlich, A., Lehmann, R. & Schleicher, E. D. High glucose-induced transforming growth factor beta1 production is mediated by the hexosamine pathway in porcine glomerular mesangial cells. J. Clin. Invest.101, 160–169 (1998). ArticleCASPubMedPubMed Central Google Scholar
Marshall, S., Bacote, V. & Traxinger, R. R. Discovery of a metabolic pathway mediating glucose-induced desensitization of the glucose transport system. Role of hexosamine biosynthesis in the induction of insulin resistance. J. Biol. Chem.266, 4706–4712 (1991). ArticleCASPubMed Google Scholar
Chen, Y. Q. et al. Sp1 sites mediate activation of the plasminogen activator inhibitor-1 promoter by glucose in vascular smooth muscle cells. J. Biol. Chem.273, 8225–8231 (1998). ArticleCASPubMed Google Scholar
Goldberg, H. J., Scholey, J. & Fantus, I. G. Glucosamine activates the plasminogen activator inhibitor 1 gene promoter through Sp1 DNA binding sites in glomerular mesangial cells. Diabetes49, 863–871 (2000). ArticleCASPubMed Google Scholar
Kadonaga, J. T., Courey, A. J., Ladika, J. & Tjian, R. Distinct regions of Sp1 modulate DNA binding and transcriptional activation. Science242, 1566–1570 (1988). ArticleADSCASPubMed Google Scholar
Haltiwanger, R. S., Grove, K. & Philipsberg, G. A. Modulation of O-linked N-acetylglucosamine levels on nuclear and cytoplasmic proteins in vivo using the peptide O-GlcNAc-beta-N-acetylglucosaminidase inhibitor O-(2-acetamido-2-deoxy-D-glucopyranosylidene)amino-N-phenylcarbamate. J. Biol. Chem.273, 3611–3617 (1998). ArticleCASPubMed Google Scholar
Hart, G. W. Dynamic O-linked glycosylation of nuclear and cytoskeletal proteins Annu. Rev. Biochem.66, 315–335 (1997). ArticleCASPubMed Google Scholar
Du, X. D. et al. Hyperglycemia inhibits endothelial nitric oxide synthase activity by posttranslational modification at the AKT site. J. Clin. Invest. (in the press).
Lee, A. Y., Chung, S. K. & Chung, S. S. Demonstration that polyol accumulation is responsible for diabetic cataract by the use of transgenic mice expressing the aldose reductase gene in the lens. Proc. Natl Acad. Sci. USA92, 2780–2784 (1995). ArticleADSCASPubMedPubMed Central Google Scholar
Nishikawa, T. et al. Normalizing mitochondrial superoxide production blocks three pathways of hyperglycaemic damage. Nature404, 787–790 (2000). ArticleADSCASPubMed Google Scholar
Giugliano, D., Ceriello, A. & Paolisso, G. Oxidative stress and diabetic vascular complications. Diabetes Care19, 257–267 (1996). ArticleCASPubMed Google Scholar
Giardino, I., Edelstein, D. & Brownlee, M. BCL-2 expression or antioxidants prevent hyperglycemia-induced formation of intracellular advanced glycation endproducts in bovine endothelial cells. J. Clin. Invest.97, 1422–1428 (1996). ArticleCASPubMedPubMed Central Google Scholar
Korshunov, S. S., Skulachev, V. P. & Starkov, A. A. High protonic potential actuates a mechanism of production of reactive oxygen species in mitochondria. FEBS Lett.416, 15–18 (1997). ArticleCASPubMed Google Scholar
Craven, R. P., Phillip, S. L., Melhem, M. F., Liachenko, J. & De Rubertis, F. R. Overexpression of Mn2+ superoxide dismutase suppresses increases in collagen accumulation induced by culture in measangial cells in high media glucose. Metabolism (in the press).
Yamagishi, S. I., Edelstein, D., Du, X. L. & Brownlee, M. Hyperglycemia potentiates collagen-induced platelet activation through mitochondrial superoxide overproduction. Diabetes50, 1491–1494 (2001). ArticleCASPubMed Google Scholar
Craven, P. A., Melham, M. F., Phillip, S. L. & DeRubertis, F. R. Overexpression of Cu2+/Zn2+ superoxide dismutase protects against early diabetic glomerular injury in transgenic mice. Diabetes50, 2114–2125 (2001). ArticleCASPubMed Google Scholar
Engerman, R. L. & Kern, T. S. Progression of incipient diabetic retinopathy during good glycemic control. Diabetes36, 808–812 (1987). ArticleCASPubMed Google Scholar
The Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications Research Group. Retinopathy and nephropathy in patients with type 1 diabetes four years after a trial of intensive therapy. N. Engl. J. Med.342, 381–389 (2000).
Quinn, M., Angelico, M. C., Warram, J. H. & Krolewski, A. S. Familial factors determine the development of diabetic nephropathy in patients with IDDM. Diabetologia39, 940–945 (1996). ArticleCASPubMed Google Scholar
The Diabetes Control and Complications Trial Research Group. Clustering of long-term complications in families with diabetes in the diabetes control and complications trial. Diabetes46, 1829–1839 (1997).
Wagenknecht, L. E. et al. Familial aggregation of coronary artery calcium in families with type 2 diabetes. Diabetes50, 861–866 (2001). ArticleCASPubMed Google Scholar
Kowluru, R. A., Tang, J. & Kern, T. S. Abnormalities of retinal metabolism in diabetes and experimental galactosemia. VII. Effect of long-term administration of antioxidants on the development of retinopathy. Diabetes50, 1938–1942 (2001). ArticleCASPubMed Google Scholar
Ting, H. H. et al. Vitamin C improves endothelium-dependent vasodilation in patients with non-insulin-dependent diabetes mellitus. J. Clin. Invest.97, 22–28 (1996). ArticleCASPubMedPubMed Central Google Scholar
Heart Outcomes Prevention Evaluation Study Investigators. Effects of ramipril on cardiovascular and microvascular outcomes in people with diabetes mellitus: results of the HOPE study and MICRO-HOPE substudy. Lancet355, 253–259 (2000).
Salvemini, D. et al. A nonpeptidyl mimic of superoxide dismutase with therapeutic activity in rats. Science286, 304–306 (1999). ArticleCASPubMed Google Scholar